Intrinsic Value of S&P & Nasdaq Contact Us

PRF Technologies Ltd. PRFX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
21/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

PRF Technologies Ltd. (PRFX) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

Analysts estimate Earnings Per Share (EPS) of $-394.80 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-32.16 vs est $-394.80 (beat +91.9%). 2025: actual $-7.47 vs est $-241.20 (beat +96.9%). Analyst accuracy: 0%.

PRFX Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to PRF Technologies Ltd. in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — PRFX

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$32.16 vs Est –$394.80 ▲ 1,127.6% off
2025 Actual –$7.47 vs Est –$241.20 ▲ 3,128.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — PRFX

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2025 Actual $0.000B vs Est $0.019B ▼ 113,464.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message